产品名称 | NebuSelect™ Recombinant Human PILRA, His-tag |
---|---|
目录号 | NBL-241276 |
别名 | PILRA |
外观 | see COA |
分子量 | Gln20-Ala197 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9UKJ1-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241276-100ug | 100ug | Inquire | Inquire | |
NBL-241276-1mg | 1mg | Inquire | Inquire | |
NBL-241276-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human PILRA, His-tag
Catalog#:
NBL-241276
Description:
NebuSelect™ Recombinant Human PILRA, His-tag(Cat#NBL-241276) is expressed in HEK293 with His tag at the C-terminus.It contains Gln20-Ala197.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 21.32 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
PILRA
Target Information:
Alzheimer's disease (AD) is a neurodegenerative disease characterized by a progressive decline in cognitive performance; Mild Cognitive Impairment (MCI) is instead an objective decline in cognitive performance that does not reach pathology. Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a cell surface inhibitory receptor that was recently suggested to be involved in AD pathogenesis. In particular, the arginine-to-glycine substitution in position 78 (R78, rs1859788) was shown to be protective against AD.
Amino Acid Sequence:
Gln20-Ala197
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.